Subcutaneous low-dose azacitidine as maintenance therapy following hematopoietic stem cell transplantation for acute myeloid leukemia and high-risk myelodysplastic syndrome–A propensity score matched analysis

Américo, A. D., Silva, C. C., Kerbauy, M. N., Arcuri, L. J., Ribeiro, A. A. F., Hamerschlak, N., & Santos, F. P. S. (2024, December 1). Subcutaneous low-dose azacitidine as maintenance therapy following hematopoietic stem cell transplantation for acute myeloid leukemia and high-risk myelodysplastic syndrome–A propensity score matched analysis. Hematology, Transfusion and Cell Therapy. Elsevier Editora Ltda. https://doi.org/10.1016/j.htct.2024.03.006